donepezil and n-((3-isopropylisoxazol-5-yl)methyl)-4-methoxy-3-((1-methylpiperidin-4-yl)oxy)benzamide

donepezil has been researched along with n-((3-isopropylisoxazol-5-yl)methyl)-4-methoxy-3-((1-methylpiperidin-4-yl)oxy)benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bertron, JL; Blakely, RD; Blobaum, AL; Dickerson, JW; Ennis, EA; Lindsley, CW; Locuson, CW; Rook, JM; Tarr, CJ; Wright, J	1

Other Studies

1 other study(ies) available for donepezil and n-((3-isopropylisoxazol-5-yl)methyl)-4-methoxy-3-((1-methylpiperidin-4-yl)oxy)benzamide

Article	Year
Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compound. Bioorganic & medicinal chemistry letters, 2016, 10-01, Volume: 26, Issue:19 Topics: Animals; Benzamides; Dose-Response Relationship, Drug; Half-Life; Inhibitory Concentration 50; Isoxazoles; Membrane Transport Proteins; Oxazoles; Piperidines; Rats; Structure-Activity Relationship	2016

Article

Year

Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compound.

Bioorganic & medicinal chemistry letters, 2016, 10-01, Volume: 26, Issue:19

Topics: Animals; Benzamides; Dose-Response Relationship, Drug; Half-Life; Inhibitory Concentration 50; Isoxazoles; Membrane Transport Proteins; Oxazoles; Piperidines; Rats; Structure-Activity Relationship

2016